(Q44975422)

7 December 2017

title

Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro (English)

1 reference

7 December 2017

1 reference

6

1 reference

7 December 2017

5

Ernst J Rummeny

1 reference

7 December 2017

Stephan Metz

1

1 reference

7 December 2017

Gabriel Bonaterra

series ordinal

2

1 reference

7 December 2017

Martina Rudelius

series ordinal

3

1 reference

7 December 2017

Marcus Settles

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

13 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

14

1 reference

7 December 2017

issue

10

1 reference

7 December 2017

page(s)

1851-1858

1 reference

Phase I clinical evaluation of a new iron oxide MR contrast agent.

7 December 2017

cites work

1 reference

12 December 2020

Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow

1 reference

12 December 2020

Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.

1 reference

12 December 2020

Ceramide induces aSMase expression: implications for oxLDL-induced apoptosis

1 reference

12 December 2020

Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging

1 reference

12 December 2020

Extra- and intracellular accumulation of ultrasmall superparamagnetic iron oxides (USPIO) in experimentally induced abscesses of the peripheral soft tissues and their effects on magnetic resonance imaging.

1 reference

12 December 2020

In vitro characterization of two different ultrasmall iron oxide particles for magnetic resonance cell tracking

1 reference

12 December 2020

Dose and scanning delay using USPIO for central nervous system macrophage imaging

1 reference

12 December 2020

Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran-magnetite particles

1 reference

12 December 2020

Induction of mitochondrial manganese superoxide dismutase in macrophages by oxidized LDL: its relevance in atherosclerosis of humans and heritable hyperlipidemic rabbits

1 reference

12 December 2020

Imaging single mammalian cells with a 1.5 T clinical MRI scanner.

1 reference

12 December 2020

YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability.

1 reference

12 December 2020

Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.

1 reference

12 December 2020

Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells

1 reference

12 December 2020

Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.

1 reference

12 December 2020

Magnetically labeled cells can be detected by MR imaging.

1 reference

12 December 2020

Targeting of hematopoietic progenitor cells with MR contrast agents.

1 reference

12 December 2020

Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging

1 reference

12 December 2020

Surface properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil

1 reference

12 December 2020

Superparamagnetic iron oxide: pharmacokinetics and toxicity

1 reference

12 December 2020

Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents

1 reference

12 December 2020

Comparison of two blood pool contrast agents for 0.5-T MR angiography: experimental study in rabbits

1 reference

12 December 2020

10.1007/S00330-004-2405-2

Identifiers

DOI

1 reference

7 December 2017

1 reference